Vitamin D and Skin Health: Barrier Function, Immunity, and Skin Conditions

Vitamin D is unusual among vitamins because the skin is both its primary production site and a major target organ. Keratinocytes synthesise vitamin D3 (cholecalciferol) from 7-dehydrocholesterol on UV-B exposure, convert it to the active form 1,25-dihydroxyvitamin D (calcitriol) locally, and respond to it through vitamin D receptors (VDR) expressed throughout the epidermis and dermis. This makes vitamin D simultaneously a systemic hormone and a local autocrine signalling molecule in skin — a dual role that explains its surprisingly broad effects on barrier function, immune defence, wound healing, and inflammatory skin conditions.

Vitamin D Synthesis in the Skin

The synthesis pathway begins in the epidermis. UV-B radiation (290–315nm) converts 7-dehydrocholesterol in keratinocytes to previtamin D3, which isomerises thermally to vitamin D3. This is then hydroxylated in the liver to 25-hydroxyvitamin D (25(OH)D — the form measured in blood tests), and further hydroxylated in the kidneys to the active form, 1,25-dihydroxyvitamin D (calcitriol). Critically, keratinocytes themselves can perform this final hydroxylation step locally — producing calcitriol for autocrine and paracrine signalling without requiring systemic activation. This local production is why skin vitamin D effects are somewhat independent of systemic vitamin D status.

The implication for photoprotection is one of the most discussed topics in vitamin D-skin science: does daily SPF use reduce vitamin D synthesis significantly? The evidence suggests that real-world SPF use, with its typical underapplication and incomplete coverage, reduces but does not eliminate cutaneous vitamin D synthesis. People who are consistently high SPF users should ensure adequate vitamin D intake through diet or supplementation rather than relying on UV exposure.

What Vitamin D Does in the Skin

Keratinocyte Differentiation and Barrier Lipid Synthesis

Calcitriol promotes terminal differentiation of keratinocytes — the process by which keratinocytes mature and eventually become the flattened, lipid-rich corneocytes of the stratum corneum. It upregulates the expression of involucrin, loricrin, and filaggrin — structural proteins essential to the cornified envelope and to the natural moisturising factors derived from filaggrin breakdown. Vitamin D deficiency impairs this differentiation programme, contributing to reduced barrier integrity and lower NMF content. The association between filaggrin deficiency, vitamin D insufficiency, and atopic dermatitis has driven substantial research interest in vitamin D as a modifier of barrier function in eczema-prone skin.

Cutaneous Immune Modulation

Vitamin D has complex effects on cutaneous immunity — broadly anti-inflammatory at the adaptive immune level while supporting innate immune defence. Calcitriol suppresses Th1 and Th17 inflammatory pathways (relevant to psoriasis and chronic inflammatory skin conditions) while upregulating the production of cathelicidin (LL-37), an antimicrobial peptide that defends against bacterial, viral, and fungal pathogens in the skin. This dual role — reducing aberrant inflammation while maintaining antimicrobial defence — makes vitamin D uniquely relevant to conditions where both processes are dysregulated, including atopic dermatitis and rosacea.

Wound Healing

VDR expression increases significantly at wound sites, and calcitriol promotes keratinocyte migration, proliferation, and angiogenesis during the healing cascade. Animal studies consistently show impaired wound healing in vitamin D-deficient subjects, and some human studies have found associations between low vitamin D status and delayed wound healing. The clinical relevance for normal skin trauma is modest, but for skin that already heals slowly — mature skin, skin on diabetes medication, post-procedure skin — vitamin D adequacy may be a meaningful supporting factor.

Vitamin D and Specific Skin Conditions

Vitamin D Deficiency: How Common Is It and What Does It Look Like in Skin?

Vitamin D deficiency is more prevalent than most people expect. Estimates suggest that over 40% of adults in the US and similar proportions in northern Europe have serum 25(OH)D below 50 nmol/L — the threshold commonly used to define insufficiency — with higher rates in people who spend limited time outdoors, have darker skin tones (which require more UV exposure to produce equivalent vitamin D), consistently use high-factor sunscreen, or live at high latitudes where winter UV-B levels are insufficient for cutaneous synthesis regardless of exposure time.

The skin-specific signs of vitamin D deficiency are not as clinically distinct as, say, the signs of zinc or iron deficiency — there is no pathognomonic rash. What is consistently observed in populations with low vitamin D is increased severity of atopic dermatitis, increased susceptibility to skin infections (reduced cathelicidin production), and impaired barrier recovery after disruption. Psoriasis flares are also associated with low vitamin D status in some studies, though the direction of causality is debated — psoriasis patients often have reduced sun exposure due to disease management and photosensitising medications.

The practical check is a serum 25(OH)D blood test — the standard measure of vitamin D status. Optimal levels for skin health (and general health) are generally considered to be 50–80 nmol/L (20–32 ng/mL). Levels below 30 nmol/L represent frank deficiency. If you use SPF consistently year-round, have darker skin, or spend most of your time indoors, it is worth checking and supplementing if below range — the oral supplement dose required to maintain adequate levels is typically 1,000–2,000 IU daily for most adults, though individual requirements vary.

The SPF and Vitamin D Paradox

One of the most frequently raised objections to daily sunscreen use is that it blocks vitamin D synthesis — creating a conflict between skin cancer and photoageing prevention on one side and vitamin D sufficiency on the other. The evidence suggests this concern is real but substantially overstated in the context of normal SPF use behaviour. Controlled studies applying sunscreen at the test dose (2mg/cm²) do reduce cutaneous vitamin D synthesis by 95–99% — but real-world SPF application at the typical 20–40% of test dose, with missed areas, reapplication gaps, and incidental outdoor exposure, leaves substantial vitamin D synthesis capacity intact for most people.

A 2019 study by Young et al. following consistent sunscreen users through a UK summer found no significant reduction in serum 25(OH)D compared to controls — suggesting that real-world SPF use does not substantially compromise vitamin D status in the majority of people. The groups most at risk of SPF-related vitamin D insufficiency are those who are already at high deficiency risk for other reasons: people with very dark skin tones (who need more UV time regardless), people in low-UV environments, and people who apply SPF meticulously to all exposed areas with proper reapplication. For these groups, oral vitamin D supplementation is the right answer — not compromising SPF protection.

The takeaway is straightforward: protect the skin from UV with SPF 50 daily, and maintain vitamin D status through diet (oily fish, egg yolks, fortified foods) or a daily supplement. These are not competing strategies. The skin cancer and photoageing risk from unprotected UV is cumulative and substantial; the vitamin D need is easily and cheaply met orally.

Topical Vitamin D in Cosmetics

Prescription topical vitamin D analogues — calcipotriol and calcitriol — are well-established treatments for psoriasis and have decades of clinical evidence. Cosmetic topical vitamin D is a different matter. Vitamin D3 (cholecalciferol) in cosmetics is increasingly included in formulations, but the evidence that it produces the same effects as prescription analogues at cosmetic concentrations is limited. The molecule must be converted to calcitriol to be active, and the conversion efficiency in non-prescription formulations is uncertain. The most practical approach for skin health remains ensuring systemic adequacy through diet and supplementation, rather than relying on cosmetic topical delivery. For a complementary look at another fat-soluble vitamin in skincare, see our guides on vitamin E in skincare and the role of vitamin C, E and ferulic acid together.